Why Did Sucampo Pharma Shares Just Get Upgraded To Buy?
April 20, 2016 at 09:34 AM EDT
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) announced the failure of its Phase IIa trial of cobiprostone in patients with refractory ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.